Browsing Tag
European Commission
160 posts
EU launches full-scale investigation into Microsoft, Activision deal
The European Commission has launched a full-scale phase 2 investigation to evaluate the previously announced acquisition of Activision…
Greece-Bulgaria Interconnection gas pipeline : IGI Poseidon begins commercial operation
IGI Poseidon, through its subsidiary ICGB AD, has commenced commercial operation of the Greece-Bulgaria Interconnection gas pipeline (IGB)…
Cara Therapeutics, VFMCRP get EC approval for Kapruvia for pruritus
Cara Therapeutics and Vifor Fresenius Medical Care Renal Pharma (VFMCRP) said that Kapruvia (difelikefalin) has secured approval from…
Chinook Therapeutics gets orphan drug status from EC for atrasentan in IgAN
Chinook Therapeutics, a US-based biopharma company, has secured orphan drug designation for atrasentan from the European Commission (EC)…
EC approves sale of Aegon’s CEE businesses to Vienna Insurance
The European Commission (EC) has approved the €830 million sale of Dutch insurance group Aegon’s Central and Eastern…
Aon, Willis Towers Watson $30bn merger gets EC approval
Aon and Willis Towers Watson said that the European Commission (EC) has given conditional approval for their proposed…
Aon to sell German retirement and investment business to Lane Clark & Peacock
Professional services firm Aon has agreed to divest its German retirement and investment business to Lane Clark &…
Bioniz Therapeutics gets EC orphan drug status for BNZ-1 for CTCL
Bioniz Therapeutics has secured orphan drug designation for BNZ-1 from the European Commission (EC) for the treatment of…
Janssen Covid‑19 vaccine gets conditional marketing authorization in EU
The European Commission has granted a conditional marketing authorization (CMA) for the single dose Janssen Covid‑19 vaccine developed…
Bristol Myers Squibb’s Opdivo receives EC approval for second-line treatment of ESCC
Bristol Myers Squibb (BMS) has achieved a significant milestone with the approval of its immunotherapy drug, Opdivo (nivolumab),…